IBDEI2TO ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47378,0)
 ;;=C82.64^^209^2346^94
 ;;^UTILITY(U,$J,358.3,47378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47378,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,47378,1,4,0)
 ;;=4^C82.64
 ;;^UTILITY(U,$J,358.3,47378,2)
 ;;=^5001525
 ;;^UTILITY(U,$J,358.3,47379,0)
 ;;=C82.65^^209^2346^97
 ;;^UTILITY(U,$J,358.3,47379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47379,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,47379,1,4,0)
 ;;=4^C82.65
 ;;^UTILITY(U,$J,358.3,47379,2)
 ;;=^5001526
 ;;^UTILITY(U,$J,358.3,47380,0)
 ;;=C82.66^^209^2346^100
 ;;^UTILITY(U,$J,358.3,47380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47380,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,47380,1,4,0)
 ;;=4^C82.66
 ;;^UTILITY(U,$J,358.3,47380,2)
 ;;=^5001527
 ;;^UTILITY(U,$J,358.3,47381,0)
 ;;=C82.67^^209^2346^102
 ;;^UTILITY(U,$J,358.3,47381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47381,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Spleen
 ;;^UTILITY(U,$J,358.3,47381,1,4,0)
 ;;=4^C82.67
 ;;^UTILITY(U,$J,358.3,47381,2)
 ;;=^5001528
 ;;^UTILITY(U,$J,358.3,47382,0)
 ;;=C82.68^^209^2346^101
 ;;^UTILITY(U,$J,358.3,47382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47382,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,47382,1,4,0)
 ;;=4^C82.68
 ;;^UTILITY(U,$J,358.3,47382,2)
 ;;=^5001529
 ;;^UTILITY(U,$J,358.3,47383,0)
 ;;=C82.69^^209^2346^95
 ;;^UTILITY(U,$J,358.3,47383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47383,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,47383,1,4,0)
 ;;=4^C82.69
 ;;^UTILITY(U,$J,358.3,47383,2)
 ;;=^5001530
 ;;^UTILITY(U,$J,358.3,47384,0)
 ;;=C82.80^^209^2346^199
 ;;^UTILITY(U,$J,358.3,47384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47384,1,3,0)
 ;;=3^Follicular Lymphoma NEC,Unspec Site
 ;;^UTILITY(U,$J,358.3,47384,1,4,0)
 ;;=4^C82.80
 ;;^UTILITY(U,$J,358.3,47384,2)
 ;;=^5001531
 ;;^UTILITY(U,$J,358.3,47385,0)
 ;;=C82.81^^209^2346^192
 ;;^UTILITY(U,$J,358.3,47385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47385,1,3,0)
 ;;=3^Follicular Lymphoma NEC,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,47385,1,4,0)
 ;;=4^C82.81
 ;;^UTILITY(U,$J,358.3,47385,2)
 ;;=^5001532
 ;;^UTILITY(U,$J,358.3,47386,0)
 ;;=C82.82^^209^2346^196
 ;;^UTILITY(U,$J,358.3,47386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47386,1,3,0)
 ;;=3^Follicular Lymphoma NEC,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,47386,1,4,0)
 ;;=4^C82.82
 ;;^UTILITY(U,$J,358.3,47386,2)
 ;;=^5001533
 ;;^UTILITY(U,$J,358.3,47387,0)
 ;;=C82.83^^209^2346^194
 ;;^UTILITY(U,$J,358.3,47387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47387,1,3,0)
 ;;=3^Follicular Lymphoma NEC,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,47387,1,4,0)
 ;;=4^C82.83
 ;;^UTILITY(U,$J,358.3,47387,2)
 ;;=^5001534
 ;;^UTILITY(U,$J,358.3,47388,0)
 ;;=C82.84^^209^2346^190
 ;;^UTILITY(U,$J,358.3,47388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47388,1,3,0)
 ;;=3^Follicular Lymphoma NEC,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,47388,1,4,0)
 ;;=4^C82.84
 ;;^UTILITY(U,$J,358.3,47388,2)
 ;;=^5001535
 ;;^UTILITY(U,$J,358.3,47389,0)
 ;;=C82.85^^209^2346^193
 ;;^UTILITY(U,$J,358.3,47389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47389,1,3,0)
 ;;=3^Follicular Lymphoma NEC,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,47389,1,4,0)
 ;;=4^C82.85
 ;;^UTILITY(U,$J,358.3,47389,2)
 ;;=^5001536
 ;;^UTILITY(U,$J,358.3,47390,0)
 ;;=C82.86^^209^2346^195
